Oncomed Revenue and Competitors
Estimated Revenue & Valuation
- Oncomed's estimated annual revenue is currently $3.4M per year.
- Oncomed's estimated revenue per employee is $77,500
- Oncomed's total funding is $210.1M.
Employee Data
- Oncomed has 44 Employees.
- Oncomed grew their employee count by 0% last year.
Oncomed's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP Regulatory Affairs & Quality Assurance | Reveal Email/Phone |
2 | SVP Clinical Research & Development | Reveal Email/Phone |
Oncomed Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Oncomed?
OncoMed Pharmaceuticals was founded in August 2004 by Drs. Michael F. Clarke and Max Wicha who led the discovery of \"cancer stem cells\". Cancer stem cells are a recently characterized type of rare tumor cell believed to seed the growth of cancers and underlie cancer\'s ability to take root in tissues (metastasize). OncoMed\'s mission is to translate the company\'s ground-breaking insights into novel medicines capable of eradicating these tumor \"progenitor\" cells to halt the spread of solid tumors.
keywords:N/A
$210.1M
Total Funding
44
Number of Employees
$3.4M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Oncomed News
Oncologista explica fatores de risco e a importância de identificar e acompanhar doenças digestivas. TOPO. Por Oncomed. 18/04/2022 17h58...
There is research activity going on for the antibodies. Many companies like the AbbVie, Roche, Amgen, OncoMed Pharmaceuticals and many others...
Editor’s note: William D. Waddill is the Senior Vice President and Chief Financial Officer of OncoMed Pharmaceuticals. Small biotechnology companies are leading innovation across the country. My company, OncoMed Pharmaceuticals, is working at the cutting edge of oncology research, focusing on a ...
OncoMed Pharmaceuticals, a company working to fight cancer using stem cells, added a $93 million tranche to a second round of funding that now totals $154 million. The money will be used to push its lead antibody candidate through phase-two clinical trials. The Redwood City, Calif. firm special ...
TODAY’S HEADLINES: Cancer stem-cell co. OncoMed strikes GSK partnership worth up to $1.4B (release) Kosmix pulls in $10M for health, lifestyle search (release) CDI Bioscience pulls in $3M for protein-production improvements (release) UroMedica takes in $7M for incontinence devices (VentureWi ...
Other Companies in Redwood City
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.2M | 44 | 0% | N/A |
#2 | $7.4M | 44 | 22% | N/A |
#3 | $11.6M | 44 | -2% | N/A |
#4 | $11.9M | 45 | 7% | N/A |
#5 | $3.5M | 45 | -2% | $50.4M |